Integra LifeSciences Holdings Corp. (IART) reported GAAP net loss of $4.1 million, or $0.15 per share, for the first quarter, as against a profit of $6.7 million, or $0.23 per share, a year ago. On average, 14 analysts polled by Thomson Reuters expected earnings per share of $0.45 for the quarter. Analysts' estimates typically exclude one-time items.
Total revenues for the recent quarter were $196.7 million, reflecting an increase of $0.5 million over the first quarter of 2012, with currency exchange rates having a negligible effect on revenues. Analysts estimated revenues of $197.87 million for the quarter.
For 2013, the company now sees revenues of $840 million - $852 million. Also, Integra LifeSciences is revising its expectations for GAAP earnings per share to between $0.92 and $1.22 and for adjusted earnings per share to between $2.40 and $2.70.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.